A detailed history of Cwm, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Cwm, LLC holds 197 shares of ARVN stock, worth $5,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
197
Previous 245 19.59%
Holding current value
$5,340
Previous $7,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$23.66 - $32.73 $1,135 - $1,571
-48 Reduced 19.59%
197 $5,000
Q2 2024

Jul 09, 2024

BUY
$24.46 - $40.4 $2,494 - $4,120
102 Added 71.33%
245 $7,000
Q4 2023

Feb 01, 2024

SELL
$14.19 - $42.33 $9,322 - $27,810
-657 Reduced 82.13%
143 $6,000
Q3 2023

Oct 11, 2023

BUY
$19.64 - $28.21 $569 - $818
29 Added 3.76%
800 $16,000
Q2 2023

Aug 03, 2023

BUY
$21.73 - $31.43 $7,540 - $10,906
347 Added 81.84%
771 $19,000
Q1 2023

Apr 28, 2023

BUY
$26.15 - $37.26 $5,700 - $8,122
218 Added 105.83%
424 $12,000
Q4 2022

Feb 01, 2023

SELL
$32.47 - $57.24 $7,338 - $12,936
-226 Reduced 52.31%
206 $7,000
Q3 2022

Oct 27, 2022

BUY
$41.87 - $57.99 $1,046 - $1,449
25 Added 6.14%
432 $19,000
Q2 2022

Jul 28, 2022

BUY
$36.01 - $74.24 $5,365 - $11,061
149 Added 57.75%
407 $17,000
Q1 2022

Apr 21, 2022

BUY
$60.27 - $81.57 $2,229 - $3,018
37 Added 16.74%
258 $17,000
Q1 2021

Sep 15, 2021

BUY
$58.19 - $91.37 $12,859 - $20,192
221 New
221 $17,000
Q1 2021

Apr 27, 2021

SELL
$58.19 - $91.37 $12,859 - $20,192
-221 Closed
0 $0
Q4 2020

Sep 15, 2021

BUY
$20.19 - $84.93 $4,461 - $18,769
221 New
221 $17,000
Q4 2020

Jan 27, 2021

SELL
$20.19 - $84.93 $4,461 - $18,769
-221 Closed
0 $0
Q3 2020

Sep 15, 2021

BUY
$22.99 - $36.34 $5,080 - $8,031
221 New
221 $17,000
Q3 2020

Oct 19, 2020

SELL
$22.99 - $36.34 $5,080 - $8,031
-221 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$29.88 - $56.74 $6,603 - $12,539
221 New
221 $17,000
Q2 2020

Jul 22, 2020

SELL
$29.88 - $56.74 $6,603 - $12,539
-221 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$33.0 - $54.5 $7,293 - $12,044
221 New
221 $17,000
Q1 2020

Apr 28, 2020

SELL
$33.0 - $54.5 $7,293 - $12,044
-221 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$15.39 - $44.38 $3,401 - $9,807
221 New
221 $17,000
Q4 2019

Jan 27, 2020

SELL
$15.39 - $44.38 $3,401 - $9,807
-221 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$21.55 - $27.61 $4,762 - $6,101
221 New
221 $17,000
Q3 2019

Oct 22, 2019

SELL
$21.55 - $27.61 $4,762 - $6,101
-221 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$15.96 - $23.8 $3,527 - $5,259
221 New
221 $17,000
Q2 2019

Jul 31, 2019

SELL
$15.96 - $23.8 $3,527 - $5,259
-221 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$13.55 - $23.79 $2,994 - $5,257
221 New
221 $0

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.44B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.